Cash Flow

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 12, 2016
Sep. 30, 2017
Sep. 12, 2016
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities            
Net income (loss)         $ 43,463  
Derivative contracts:            
Share-based compensation (equity-classified)         2,700  
Cash flows from financing activities            
Proceeds received from rights offering, net         100  
Cash and cash equivalents – beginning of period         6,761  
Cash and cash equivalents – end of period     $ 7,487   7,487  
Successor [Member]            
Cash flows from operating activities            
Net income (loss) $ (3,441)   (5,947)   43,463  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:            
Non-cash reorganization items 0       0  
Depreciation, depletion and amortization 2,029   10,659   31,545  
Accretion of firm transportation obligation 0       0  
Derivative contracts:            
Net (gains) losses 4,369       (15,802)  
Cash settlements, net 0       (1,670)  
Loss (gain) on sales of assets, net 0       60  
Non-cash exploration expense 0       0  
Non-cash interest expense 38       1,362  
Share-based compensation (equity-classified) 0       2,707  
Other, net 0       59  
Changes in operating assets and liabilities, net 585       (11,430)  
Net cash provided by operating activities 3,580       50,294  
Cash flows from investing activities            
Acquisition, net 0       (200,162)  
Capital expenditures 0       (67,844)  
Proceeds from sales of assets, net 0       0  
Other, net 0       0  
Net cash used in investing activities 0       (268,006)  
Cash flows from financing activities            
Proceeds from credit facility borrowings 0       39,000  
Repayment of credit facility borrowings (21,000)       (7,000)  
Proceeds from second lien facility, net 0       196,000  
Debt issuance costs paid 0       (9,562)  
Proceeds received from rights offering, net 0       55  
Other, net 0       (55)  
Net cash provided by (used in) financing activities (21,000)       218,438  
Net increase (decrease) in cash and cash equivalents (17,420)       726  
Cash and cash equivalents – beginning of period         6,761  
Cash and cash equivalents – end of period 13,994   $ 7,487   7,487 $ 13,994
Cash paid for:            
Interest, net of amounts capitalized 0       1,596  
Income taxes, net of (refunds) 0       0  
Reorganization items, net 0       1,098  
Non-cash investing and financing activities:            
Common stock issued in exchange for liabilities 0       0  
Changes in accrued liabilities related to capital expenditures 0       8,140  
Derivatives settled to reduce outstanding debt 0       $ 0  
Predecessor [Member]            
Cash flows from operating activities            
Net income (loss)   $ 1,155,341   $ 1,054,602    
Adjustments to reconcile net income (loss) to net cash provided by operating activities:            
Non-cash reorganization items       (1,178,302)    
Depreciation, depletion and amortization   8,024   33,582    
Accretion of firm transportation obligation       317   300
Derivative contracts:            
Net (gains) losses       8,333    
Cash settlements, net       48,008    
Loss (gain) on sales of assets, net       (1,261)    
Non-cash exploration expense       6,038    
Non-cash interest expense       22,188    
Share-based compensation (equity-classified)       1,511    
Other, net       (13)    
Changes in operating assets and liabilities, net       35,244    
Net cash provided by operating activities       30,247    
Cash flows from investing activities            
Acquisition, net       0    
Capital expenditures       (15,359)    
Proceeds from sales of assets, net       224    
Other, net       1,186    
Net cash used in investing activities       (13,949)    
Cash flows from financing activities            
Proceeds from credit facility borrowings       75,350    
Repayment of credit facility borrowings       (119,121)    
Proceeds from second lien facility, net       0    
Debt issuance costs paid       (3,011)    
Proceeds received from rights offering, net       49,943    
Other, net       0    
Net cash provided by (used in) financing activities       3,161    
Net increase (decrease) in cash and cash equivalents       19,459    
Cash and cash equivalents – beginning of period $ 31,414     11,955   11,955
Cash and cash equivalents – end of period   $ 31,414   31,414    
Cash paid for:            
Interest, net of amounts capitalized       4,331    
Income taxes, net of (refunds)       (35)    
Reorganization items, net       30,990    
Non-cash investing and financing activities:            
Common stock issued in exchange for liabilities       140,952    
Changes in accrued liabilities related to capital expenditures       (11,301)    
Derivatives settled to reduce outstanding debt       $ 51,979   $ 52,000

Source